{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:29:45Z","timestamp":1791343785588,"version":"4.3.1"},"reference-count":134,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.clindermatol.2010.03.020","type":"journal-article","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T09:31:28Z","timestamp":1277890288000},"page":"440-451","source":"Crossref","is-referenced-by-count":196,"title":["Healing fats of the skin: the structural and immunologic roles of the \u03c9-6 and \u03c9-3 fatty acids"],"prefix":"10.1016","volume":"28","author":[{"given":"Meagen M.","family":"McCusker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Grant-Kels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2010.03.020_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0021-9258(20)78281-5","article-title":"A new deficiency disease produced by the rigid exclusion of fat from the diet","volume":"82","author":"Burr","year":"1929","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0021-9258(20)78929-5","article-title":"On the nature and role of the fatty acids essential in nutrition","volume":"86","author":"Burr","year":"1930","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0163-7827(03)00038-9","article-title":"Problems with essential fatty acids: time for a new paradigm?","volume":"42","author":"Cunnane","year":"2003","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ajcn\/79.6.935","article-title":"Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms","volume":"79","author":"Larsson","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib5","series-title":"Perinatal strategy for preventing adult diseases: the role of long-chain polyunsaturated fatty aids","author":"Das","year":"2002"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000012803","article-title":"Australian food sources and intakes of omega-6 and omega-3 polyunsaturated fatty acids","volume":"43","author":"Ollis","year":"1999","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/biot.200600012","article-title":"Essential fatty acids: biochemistry, physiology and pathology","volume":"1","author":"Das","year":"2006","journal-title":"Biotech J"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib8","doi-asserted-by":"crossref","first-page":"8755","DOI":"10.1074\/jbc.R100062200","article-title":"The biochemistry of n-3 polyunsaturated fatty acids","volume":"277","author":"Jump","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib9","series-title":"Skin barrier","first-page":"33","article-title":"Biochemistry of human stratum corneum lipids","author":"Wertz","year":"2006"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib10","series-title":"Skin barrier","first-page":"261","article-title":"Epidermal lamellar body as a multifunctional secretory organelle","author":"Elias","year":"2006"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib11","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1172\/JCI24834","article-title":"Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer","volume":"115","author":"Akiyama","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib12","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1172\/JCI25736","article-title":"Harlequin ichthyosis unmasked: a defect of lipid transport","volume":"115","author":"Hovnanian","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0022-2275(20)34355-8","article-title":"De novo sterologenesis in the skin, II. Regulation by cutaneous barrier requirements","volume":"26","author":"Menon","year":"1985","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0022-2275(20)38670-3","article-title":"Relationship of epidermal lipogenesis to cutaneous barrier function","volume":"28","author":"Grubauer","year":"1987","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib15","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1172\/JCI107012","article-title":"Excretion of sterols from normal and hypercholesterolemic humans. Implications for sterol balance studies","volume":"51","author":"Bhattacharyya","year":"1972","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1084\/jem.141.3.620","article-title":"Isotope kinetics of human skin cholesterol secretion","volume":"141","author":"Nikkari","year":"1975","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib17","first-page":"574","article-title":"The mammalian cutaneous permeability barrier: defective barrier function in essential fatty acid deficiency correlates with abnormal intercellular lipid deposition","volume":"39","author":"Elias","year":"1978","journal-title":"Lab Invest"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0005-2760(85)90009-8","article-title":"Essential function of linoleic acid esterified in acylglycosylceramide and acylceramide in maintaining the epidermal water permeability barrier. Evidence from feeding studies with oleate, linoleate, arachidonate, columbinate and alpha-linoleate","volume":"834","author":"Hansen","year":"1985","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0005-2760(87)90018-X","article-title":"Effects of essential fatty acid deficiency on epidermal O-acylsphingolipids and transepidermal water loss in young pigs","volume":"921","author":"Melton","year":"1987","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0005-2760(83)90058-9","article-title":"Effect of essential fatty acid deficiency on the epidermal sphingolipids of the rat","volume":"753","author":"Wertz","year":"1983","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s004030000160","article-title":"Relationship between covalently bound ceramides and transepidermal water loss (TEWL)","volume":"292","author":"Meguro","year":"2000","journal-title":"Arch Derm Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1523-1747.1998.00318.x","article-title":"Expression of epidermal keratins and the cornified envelop protein involucrin is influenced by permeability barrier disruption","volume":"111","author":"Ekanayake-Mudiyanselage","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0005-2760(94)90138-4","article-title":"Evidence for a novel keratinocyte fatty acid uptake mechanism with preference for linoleic acid: comparison of oleic acid and linoleic acid uptake by cultured human keratinocytes, fibroblasts and a human hepatoma cell line","volume":"1211","author":"Schurer","year":"1994","journal-title":"Biochin Biophys Acta"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib24","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jaci.2008.01.022","article-title":"Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms","volume":"121","author":"Elias","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1467-2494.2003.00174.x","article-title":"Trends in stratum corneum research and the management of dry skin conditions","volume":"25","author":"Rawlings","year":"2003","journal-title":"Int J Cosmet Sci"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/1523-1747.ep12650440","article-title":"Epidermal HMG CoA reductase activity in essential fatty acid deficiency: barrier requirements rather than eicosanoid generation regulate cholesterol synthesis","volume":"99","author":"Proksch","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib27","series-title":"20th IFSCC International Congress","first-page":"347","article-title":"An increase in endogenous epidermal lipids improves skin barrier function","author":"Tanno","year":"2000"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib28","article-title":"New facial moisturizer technology increase exfoliation without compromising barrier function","author":"Ertel","year":"2000"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib29","article-title":"Niacinamide stimulates collagen synthesis from human dermal fibroblasts and differentiation markers in normal human epidermal keratinocytes: potential of niacinamide to normalize aged skin cells to correct homeostatic balance","author":"Oblong","year":"2001"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib30","first-page":"687","article-title":"The effect of thiols on epidermal lipid biosynthesis. Annual Meeting of The Society For Investigative Dermatology","volume":"104","author":"Zhang","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib31","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1046\/j.0022-202x.2001.01555.x","article-title":"Vitamin C stimulates sphingolipid production and markers of barrier formation in submerged human keratinocyte cultures","volume":"117","author":"Uchida","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF02507107","article-title":"Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function","volume":"288","author":"Rawlings","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ng2020","article-title":"Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema","volume":"39","author":"Sandilands","year":"2007","journal-title":"Nat Genet"},{"issue":"3 suppl 2","key":"10.1016\/j.clindermatol.2010.03.020_bib35","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/j.jaci.2009.07.012","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"124","author":"Howell","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1159\/000234245","article-title":"Essential fatty acids in serum lecithin of children with atopic dermatitis and in umbilical cord serum of infants with high or low IgE levels","volume":"82","author":"Strannegard","year":"1987","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib37","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2133.1994.tb03413.x","article-title":"Analysis of polyunsaturated fatty acids in newborn sera: a screening tool for atopic disease?","volume":"130","author":"Galli","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib38","first-page":"279","article-title":"Abnormal fatty acid composition in umbilical cord blood of infants at high risk of atopic disease","volume":"89","author":"Beck","year":"2000","journal-title":"Paediatr"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib39","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1203\/01.pdr.0000203158.31452.9e","article-title":"Breast milk fatty acids may link innate and adaptive immune regulation: analysis of soluble CD14, prostaglandin E2, and fatty acids","volume":"59","author":"Laitinen","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib40","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/ajcn\/73.4.807","article-title":"Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length","volume":"73","author":"Elias","year":"2001","journal-title":"Am J Clin Nutr"},{"issue":"1suppl","key":"10.1016\/j.clindermatol.2010.03.020_bib41","doi-asserted-by":"crossref","first-page":"367S","DOI":"10.1093\/ajcn\/71.1.367s","article-title":"Essential fatty acid metabolism and its modification in atopic eczema","volume":"71","author":"Horrobin","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib42","first-page":"285","article-title":"The effect of gamma-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitis","volume":"14","author":"Biagi","year":"1994","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib43","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/138920106779116946","article-title":"A meta-analysis of randomized, placebo-controlled clinical trials of efamol evening primrose oil in atopic eczema. Where do we go from here in light of more recent discoveries","volume":"7","author":"Morse","year":"2006","journal-title":"Curr Pharma Biotech"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib44","doi-asserted-by":"crossref","first-page":"14368","DOI":"10.1074\/jbc.273.23.14368","article-title":"Purification and characterization of a novel ceramidase from Pseudomonas aeruginosa","volume":"273","author":"Okino","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/CDLI.6.1.101-104.1999","article-title":"Ceramidase activity in bacterial skin flora as a possible cause of ceramidase deficiency in atopic dermatitis","volume":"6","author":"Ohnishi","year":"1999","journal-title":"Clin Diagn Lab Immun"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib46","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0022-2275(20)40544-9","article-title":"Effect of cutaneous permeability barrier on HMG CoA reductase, LDL receptor, and apolipoprotein E mRNA levels in the epidermis of hairless mice","volume":"33","author":"Jackson","year":"1992","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib47","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1172\/JCI114514","article-title":"Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements","volume":"85","author":"Proksch","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib48","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12340962","article-title":"Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis","volume":"109","author":"Harris","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/1523-1747.ep12665893","article-title":"Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice","volume":"104","author":"Ottey","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib50","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1194\/jlr.R700013-JLR200","article-title":"The role of epidermal lipids in cutaneous permeability barrier homeostasis","volume":"48","author":"Feingold","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0378-1119(98)00262-5","article-title":"Cloning and chromosomal localisation of the murine epidermal-type fatty acid binding protein gene (Fabpe)","volume":"215","author":"Bleck","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/1523-1747.ep12616641","article-title":"Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated faty acid-binding protein [PA-FABP] that is highly upregulated in psoriatic skin and that shares similarity to fatty acid-binding proteins","volume":"99","author":"Madsen","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/bj3020363","article-title":"Purification and characterization of the human epidermal fatty acid-binding protein: localization during epidermal cell differentiation in vivo and in vitro","volume":"302","author":"Siegenthaler","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib54","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1006\/bbrc.1993.1073","article-title":"Characterization and expression of a novel fatty acid-binding protein: the epidermal type (E-FABP)","volume":"190","author":"Siegenthaler","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib55","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1034\/j.1600-0625.2003.00051.x","article-title":"Effect of the lactic acid bacterium Streptococcus thermophilus on the stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients","volume":"12","author":"Di Marzio","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib56","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archderm.131.7.809","article-title":"Exogenous nonphysiological vs physiological lipids. Divergent mechanisms for correction of permeability barrier dysfunction","volume":"131","author":"Mao-Qiang","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib57","first-page":"414","article-title":"A topical lipid-based barrier repair formulation (EpiCeram\u2122 cream) is high effective monotherapy for moderate-to-severe pediatric atopic dermatitis","volume":"115","author":"Sugarman","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib58","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1525-1470.2006.00268.x","article-title":"Improvement of atopic dermatitis and reduction of skin allergic responses by oral intake of konjac ceramide","volume":"23","author":"Kimata","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib59","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/ajcn\/63.2.267","article-title":"Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes","volume":"63","author":"Hughes","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/ajcn\/53.1.40","article-title":"Dietary alpha-linoleic acid and immunocompetence in humans","volume":"53","author":"Kelley","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib61","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/jn\/120.1.36","article-title":"Dietary supplementation with n-3 and n-6 enriched oils influences in vivo levels of epidermal lipoxygenase products","volume":"120","author":"Miller","year":"1990","journal-title":"J Nutr"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib62","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1523-1747.ep12515911","article-title":"Dietary supplementation with ethyl ester concentrations of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative antiinflammatory metabolites","volume":"96","author":"Miller","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib63","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/1523-1747.ep12696858","article-title":"Eicosanoids in acute and chronic psoriatic lesions: Leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions","volume":"92","author":"Fogh","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/1523-1747.ep12873300","article-title":"Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis","volume":"95","author":"Black","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib65","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1203\/01.PDR.0000148279.72611.1D","article-title":"Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy","volume":"57","author":"Denburg","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1203\/01.pdr.0000250274.68571.18","article-title":"Protection of the neonate by the innate immune system of developing gut and of human milk","volume":"61","author":"Newburg","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2222.2002.01274.x","article-title":"MAS-study group. Breastfeeding duration is a risk factor for atopic eczema","volume":"32","author":"Bergmann","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib68","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1067\/mjd.2001.114741","article-title":"Breastfeeding and the onset of atopic dermatitis in childhood: A systematic review and meta-analysis of prospective studies","volume":"45","author":"Gdalevich","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib69","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.mpg.0000168992.44428.fa","article-title":"Breast milk fatty acid composition is associated with development of atopic dermatitis in the infant","volume":"41","author":"Hoppu","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib70","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1524-475x.2000.00192.x","article-title":"Epidermal growth factor and keratinocyte growth factor differentially regulate epidermal migration, growth and differentiation","volume":"8","author":"Gibbs","year":"2009","journal-title":"Wound Rep Regen"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib71","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2133.1993.tb03338.x","article-title":"Highly purified omega-3-polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double-blind, placebo-controlled multicentre study","volume":"129","author":"Henniecke-von Zepelin","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib72","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2133.1994.tb03414.x","article-title":"Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis: a double-blind, multicentre study","volume":"130","author":"Soyland","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib73","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0190-9622(98)70114-8","article-title":"Omega-3 fatty acid-bsed lipid infusion in patients with chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, multicenter trial","volume":"38","author":"Mayser","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib74","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","article-title":"Omega-3 fatty acids in inflammation and autoimmune diseases","volume":"21","author":"Simopoulos","year":"2002","journal-title":"J Amer Coll Nutr"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib75","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1159\/000419312","article-title":"Fish oil in combination with other therapies in the treatment of psoriasis","volume":"66","author":"Allen","year":"2001","journal-title":"World Rev Nutr Diet"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib76","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1158\/1940-6207.CAPR-08-0197","article-title":"Regulation of colorectal cancer cell apoptosis by the n- polyunsaturated fatty acids docosahexaenoic and eicosapentaenoic","volume":"2","author":"Giros","year":"2009","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib77","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jnutbio.2008.02.003","article-title":"The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy","volume":"19","author":"Biondo","year":"2008","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib78","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/carcin\/bgg038","article-title":"Effect of eicosapentanoic acid an omega-3 polyunsaturated fatty acid, on UVR-related skin cancer risk in humans: An assessment of early genotoxic markers","volume":"24","author":"Rhodes","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib79","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3109\/02841869609096994","article-title":"Cancers of skin, bone, connective tissue, brain, eye, thyroid and other specified and unspecified sites in Inuit","volume":"35","author":"Miller","year":"1996","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib80","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.4049\/jimmunol.171.6.3296","article-title":"Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG","volume":"171","author":"Bave","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib81","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI23025","article-title":"Human lupus autoantibody\u2013DNA complexes activated DCs through cooperation of CD32 and TLR9","volume":"115","author":"Means","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib82","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/j.2326-5205.1989.tb00024.x","article-title":"MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus","volume":"32","author":"von Wussow","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib83","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-065X.2008.00630.x","article-title":"Development of TLR inhibitors for the treatment of autoimmune diseases","volume":"223","author":"Barrat","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib84","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0952-3278(97)90533-0","article-title":"Oxidant stress, anti-oxidants and essential fatty acids in systemic lupus erythematosus","volume":"56","author":"Mohan","year":"1997","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib85","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archdermatol.2009.5","article-title":"Efficacy and safety of combination acitretin and pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial","volume":"145","author":"Mittal","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib86","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0092-8674(92)90031-7","article-title":"Control of the peroxisome beta-oxidation pathway by a novel family of nuclear hormone receptors","volume":"68","author":"Dreyer","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib87","doi-asserted-by":"crossref","first-page":"31012","DOI":"10.1016\/S0021-9258(18)47383-8","article-title":"Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element","volume":"269","author":"Vu-Dac","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib88","doi-asserted-by":"crossref","first-page":"13470","DOI":"10.1074\/jbc.270.22.13470","article-title":"Mode of action of peroxisome proliferators as hypolipidemic drugs: suppression of apolipoprotein C-III","volume":"270","author":"Hertz","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib89","doi-asserted-by":"crossref","first-page":"18767","DOI":"10.1016\/S0021-9258(17)32234-2","article-title":"Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids","volume":"269","author":"Rodriguez","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib90","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1073\/pnas.091021198","article-title":"A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport","volume":"98","author":"Oliver","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib91","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0014-5793(00)01554-4","article-title":"Activation of PPARdelta alters lipid metabolism in db\/db mice","volume":"473","author":"Leibowitz","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib92","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1189\/jlb.71.3.388","article-title":"The role of PPARs in inflammation and immunity","volume":"71","author":"Clark","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib93","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1210\/en.134.1.264","article-title":"Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance","volume":"134","author":"Hoffmann","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib94","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib95","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35154","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrfmmm.2009.06.009","article-title":"Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components","volume":"669","author":"Martin","year":"2009","journal-title":"Mutat Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib97","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X","article-title":"Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells","volume":"31","author":"Gosset","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib98","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-5793(00)02319-X","article-title":"Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells","volume":"486","author":"Faveeuw","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib99","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1046\/j.1523-1747.2003.12536.x","article-title":"Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin","volume":"121","author":"Westergaard","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0625.2006.00504.x","article-title":"Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications","volume":"16","author":"Plager","year":"2007","journal-title":"Exp. Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib101","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0303-7207(98)00214-7","article-title":"Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells","volume":"147","author":"Matsuura","year":"1999","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib102","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1046\/j.1523-1747.1998.00439.x","article-title":"Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes","volume":"111","author":"Rivier","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib103","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1046\/j.1523-1747.2001.01329.x","article-title":"Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid","volume":"116","author":"Westergaard","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib104","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1523-1747.2000.00076.x","article-title":"Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis","volume":"115","author":"Komuves","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib106","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0012-1606(86)90230-7","article-title":"Filaggrin breakdown to water binding compounds during the development of the rat stratum corneum is controlled by the water activity of the environment","volume":"115","author":"Scott","year":"1986","journal-title":"Dev Biol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib107","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1097-2765(02)00646-9","article-title":"Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway","volume":"10","author":"Di-Poi","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib108","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0625.2006.00402.x","article-title":"Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model","volume":"15","author":"Demerjian","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib109","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000068897","article-title":"Effect of topical PPARbeta\/delta and PPARgamma agonists on plaque psoriasis. A pilot study","volume":"206","author":"Kuenzli","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2133.2003.05532.x","article-title":"Peroxisome proliferator-activated receptors in cutaneous biology","volume":"149","author":"Kuenzli","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib111","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/1568010043343976","article-title":"Peroxisome proliferator-activated receptors as new molecular targets in psoriasis","volume":"3","author":"Kuenzli","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib112","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/GCO.0b013e328307ebc5","article-title":"Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients","volume":"20","author":"Palomba","year":"2008","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib113","doi-asserted-by":"crossref","first-page":"AB67","DOI":"10.1016\/j.jaad.2006.10.331","article-title":"New natural PPAR-alpha agonist for childhood atopic dermatitis: dermocorticoid-sparing and quality of life improvement [abstract]","volume":"56","author":"Msika","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib114","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1523-1747.2000.00895.x","article-title":"Oxysterols induce differentiation in human keratinoytes and increase AP-1-dependent involucrin transcrition","volume":"114","author":"Hanley","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib115","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1523-1747.1998.00139.x","article-title":"Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARalpha","volume":"110","author":"Hanley","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib116","doi-asserted-by":"crossref","first-page":"11621","DOI":"10.1021\/jf802298w","article-title":"Oregano: a source for peroxisome proliferator-activated receptor gamma antagonists","volume":"56","author":"Mueller","year":"2008","journal-title":"J Agri Food Chem"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib117","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ghir.2008.01.001","article-title":"Dietary conjugated linoleic acid increases PPAR gamma gene expression in adipose tissue of obese rat and improves insulin resistance","volume":"18","author":"Zhou","year":"2008","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib118","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbalip.2007.02.004","article-title":"Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease","volume":"1771","author":"Michalik","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib119","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1083\/jcb.200011148","article-title":"Impaired skin wound healing in peroxisome proliferator-activated receptor PPARalpha and PPARbeta mutant mice","volume":"154","author":"Michalik","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.0303-6987.2005.00345.x","article-title":"Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors","volume":"32","author":"Nijsten","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib121","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1046\/j.0022-202x.2001.01537.x","article-title":"Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation","volume":"117","author":"Kippenberger","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib122","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1523-1747.2002.01861.x","article-title":"Activators of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma","volume":"119","author":"Mossner","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib123","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1158\/1078-0432.CCR-05-2556","article-title":"Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down regulation of Akt","volume":"12","author":"Grabacka","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib124","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00403-004-0479-y","article-title":"Inhibition of melanoma metastases by fenofibrate","volume":"296","author":"Grabacka","year":"2004","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib125","first-page":"388","article-title":"PPAR gamma regulates MITF and beta catenin expression and promotes a differentiated phenotype","volume":"3","author":"Hoek","year":"2008","journal-title":"Pig Cell Mel Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib126","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1194\/jlr.M200361-JLR200","article-title":"Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids","volume":"44","author":"Lee","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib127","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib128","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1189\/jlb.1103543","article-title":"Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system","volume":"75","author":"Netea","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib129","doi-asserted-by":"crossref","first-page":"16971","DOI":"10.1074\/jbc.M312990200","article-title":"Saturated fatty acid activates but polyunsaturated fatty acid inhibits toll-like receptor 2 dimerized with toll-like receptor 6 or 1","volume":"279","author":"Lee","year":"2004","journal-title":"J Bio Chem"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaci.2006.04.034","article-title":"Lack of association between Toll-like receptor 2 and Toll-like receptor 4 polymorphisms and atopic eczema","volume":"118","author":"Weidinger","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib131","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/1523-1747.ep12276700","article-title":"An elevated level of autoantibodies against 48-50 kd keratins in the serum of patients with psoriasis","volume":"92","author":"Aoki","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib132","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2230.2008.02948.x","article-title":"Effects of antikeratin 16 antibodies on the expression of Toll-like receptors 2 and 4 in keratinocytes","volume":"34","author":"Wu","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib133","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000095056","article-title":"Differential regulation of toll-like receptor and CD14 pathways by retinoids and corticosteroids in human sebocytes","volume":"213","author":"Oeff","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2010.03.020_bib134","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1038\/jid.2009.93","article-title":"Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris","volume":"129","author":"Nakatsuji","year":"2009","journal-title":"J Invest Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X10000441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X10000441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T20:11:10Z","timestamp":1685650270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X10000441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":134,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0738081X10000441"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2010.03.020","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}